SKI Market

A+| A| A-|

Indian Indices

Sensex

77,185.56 -430.84
( -0.56%)

Global Indices

Nasdaq

52,524.20 -133.81
(-0.25%)

Dow Jones

7,536.77 -59.62
(-0.78%)

Hang Seng

67,217.35 -1,340.38
(-1.96%)

Nikkei 225

10,494.06 -3.23
(-0.03%)

Forex

USD-INR

95.45 -0.01
(-0.01%)

EUR-INR

109.10 0.17
(0.15%)

GBP-INR

127.94 0.35
(0.28%)

JPY-INR

0.59 0.00
(0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bacil Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524516

INE711D01018

17.5524281

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

34.74

53.85

EPS(TTM)

Face Value()

Div & Yield %

1.08

Back

Mangalam Worldwide consolidated net profit rises 74.57% in the December 2025 quarter

Jan 19,2026

Net profit of Mangalam Worldwide rose 74.57% to Rs 14.07 crore in the quarter ended December 2025 as against Rs 8.06 crore during the previous quarter ended December 2024. Sales rose 29.80% to Rs 350.19 crore in the quarter ended December 2025 as against Rs 269.79 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	350.19	269.79	30
OPM %	7.49	5.63	-
PBDT	16.81	10.18	65
PBT	14.24	8.03	77
NP	14.07	8.06	75

77,185.56 -430.84 ( -0.56%)

52,524.20 -133.81 (-0.25%)

7,536.77 -59.62 (-0.78%)

67,217.35 -1,340.38 (-1.96%)

10,494.06 -3.23 (-0.03%)

95.45 -0.01 (-0.01%)

109.10 0.17 (0.15%)

127.94 0.35 (0.28%)

0.59 0.00 (0.03%)